Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_12-cv-03393/USCOURTS-cand-4_12-cv-03393-60/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 15:1126 Patent Infringement

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

United States District Court 

Northern District of Californi

a

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

ANGIOSCORE, INC., 

Plaintiff, 

v. 

TRIREME MEDICAL, INC., ET AL., 

Defendants. 

Case No. 12-cv-03393-YGR 

ORDER ON PLAINTIFF'S FIRST MOTION IN 

LIMINE

 The Court, having reviewed the arguments of the parties with respect to Plaintiff AngioScore’s 

first motion in limine relating to whether testimony of Randal Farwell should be precluded at trial, 

hereby GRANTS IN PART and DENIES IN PART the motion. (Dkt. No. 593.) Mr. Farwell is 

precluded from testifying on topics as to which defendants’ 30(b)(6) witness was deposed. With 

this in mind, defendants shall have until midnight on April 15, 2015 to file a list of proposed 

topics on which Mr. Farwell may testify so that the Court may consider any arguments in 

opposition to specific subjects. 

This order terminates Docket Number 593. 

IT IS SO ORDERED. 

Dated: April 14, 2015 

______________________________________ 

 YVONNE GONZALEZ ROGERS

 UNITED STATES DISTRICT COURT JUDGE

Case 4:12-cv-03393-YGR Document 606 Filed 04/14/15 Page 1 of 1